AlphaYouAB
Insider selling
Ali Behbahani sold $781K of CRISPR Therapeutics AG (CRSP) stock
Ali Behbahani, Dir of CRISPR Therapeutics AG (CRSP), sold 13,679 shares of CRSP stock worth $781K, per an SEC Form 4 filed Sep 21, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 17, 2026, 4 days before it was made public.
CRSP has moved +1.8% since the trade date, from $57.33 to $58.33 (Sep 21, 2026 close).
- Traded
- Sep 17, 2026
- Disclosed
- Sep 21, 2026
- Filing delay
- 4 days
- Price since
- +1.8%
- Role
- Dir
- Source
- SEC Form 4
More CRSP insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.